APA (7th ed.) Citation

WL, W., D, L., E, C., A, J., MS, R., A, G., . . . S, D. (2026). Early steroid and anakinra use to manage axicabtagene ciloleucel toxicity reduces the total duration of CRS and ICANS. Blood advances, 10(10), 3313. https://doi.org/10.1182/bloodadvances.2025019031

Chicago Style (17th ed.) Citation

WL, Wang, et al. "Early Steroid and Anakinra Use to Manage Axicabtagene Ciloleucel Toxicity Reduces the Total Duration of CRS and ICANS." Blood Advances 10, no. 10 (2026): 3313. https://doi.org/10.1182/bloodadvances.2025019031.

MLA (9th ed.) Citation

WL, Wang, et al. "Early Steroid and Anakinra Use to Manage Axicabtagene Ciloleucel Toxicity Reduces the Total Duration of CRS and ICANS." Blood Advances, vol. 10, no. 10, 2026, p. 3313, https://doi.org/10.1182/bloodadvances.2025019031.